This article first appeared on GuruFocus.

Dexco SA (BSP:DXCO3) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $2.21 billion, and the earnings are expected to come in at $0.09 per share. The full year 2025's revenue is expected to be $8.41 billion, and the earnings are expected to be $0.21 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 5 Warning Signs with BSP:DXCO3.

Is BSP:DXCO3 fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for Dexco SA (BSP:DXCO3) have increased from $8.40 billion to $8.41 billion for the full year 2025. However, revenue estimates have declined from $8.89 billion to $8.85 billion for 2026. Earnings estimates for Dexco SA have decreased from $0.26 per share to $0.21 per share for the full year 2025, and from $0.26 per share to $0.13 per share for 2026.

In the previous quarter ending on 2025-06-30, Dexco SA's (BSP:DXCO3) actual revenue was $2.12 billion, which beat analysts' revenue expectations of $2.07 billion by 2.59%. Dexco SA's actual earnings were $0.04 per share, which missed analysts' earnings expectations of $0.12 per share by 67.50%. After releasing the results, Dexco SA (BSP:DXCO3) was up by 3.92% in one day.

Based on the one-year price targets offered by 7 analysts, the average target price for Dexco SA (BSP:DXCO3) is $7.93, with a high estimate of $10.00 and a low estimate of $6.50. The average target implies an upside of 51.02% from the current price of $5.25.

Based on GuruFocus estimates, the estimated GF Value for Dexco SA (BSP:DXCO3) in one year is $7.95, suggesting an upside of 51.43% from the current price of $5.25.

Based on the consensus recommendation from 7 brokerage firms, Dexco SA's (BSP:DXCO3) average brokerage recommendation is currently 2.0, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.